Robert P. Goodman

1.6k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Robert P. Goodman is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert P. Goodman has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert P. Goodman's work include Inflammatory mediators and NSAID effects (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Robert P. Goodman is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Robert P. Goodman collaborates with scholars based in United States. Robert P. Goodman's co-authors include Ted Bergstrom, Alan Brash, Robert A. Branch, Allen P. Killam, Jackson T. Wright, James M. McKenney, M. Hong Nguyen, Robert D. Arbeit, Carol A. Kauffman and Cheryl Squier and has published in prestigious journals such as Annals of Internal Medicine, American Economic Review and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Robert P. Goodman

17 papers receiving 988 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Private Demands for Public Goods

1973 698 citations Ted Bergstrom, Robert P. Goodman American Economic Review profile →

Peers

Robert P. Goodman

PSIR

PHARM

CCM

Thomas R. Oliver United States

José Miguel Cruz United States

Patricia Day Argentina

Guobao Wu China

Simon Horsburgh New Zealand

Marc Ratkovic United States

Rebecca Williams United Kingdom

Samuel O. Thier United States

Miguel Gouveia Portugal

Thomas R. Oliver United States

Robert P. Goodman

302 ×0.5

116 ×0.3

PSIR

11 ×0.1

PHARM

14 ×0.1

CCM

34 ×0.3

Citations per year, relative to Robert P. Goodman Robert P. Goodman (= 1×) peers Thomas R. Oliver

Countries citing papers authored by Robert P. Goodman

Since Specialization

Citations

This map shows the geographic impact of Robert P. Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Goodman more than expected).

Fields of papers citing papers by Robert P. Goodman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Goodman. The network helps show where Robert P. Goodman may publish in the future.

Co-authorship network of co-authors of Robert P. Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Goodman. A scholar is included among the top collaborators of Robert P. Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Goodman. Robert P. Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Nguyen, M. Hong, Carol A. Kauffman, Robert P. Goodman, et al.. (1999). Nasal Carriage of and Infection with Staphylococcus aureus in HIV-Infected Patients. Annals of Internal Medicine. 130(3). 221–225. 106 indexed citations

McKenney, James M., Jackson T. Wright, George M. Katz, & Robert P. Goodman. (1991). The Effect of Phenylpropanolamine on 24-Hour Blood Pressure in Normotensive Subjects Administered Indomethacin. DICP. 25(3). 234–239. 2 indexed citations

Townsend, Raymond R., Donald J. DiPette, Robert P. Goodman, et al.. (1990). Combined α/β-blockade versus β1-selective blockade in essential hypertension in black and white patients. Clinical Pharmacology & Therapeutics. 48(6). 665–675. 26 indexed citations

Mohanty, P K, Leonard Gonasun, Robert P. Goodman, et al.. (1988). Isradipine (PN 200-110) versus Hydrochlorothiazide in Mild to Moderate Hypertension A Multicenter Study. American Journal of Hypertension. 1(3 Pt 3). 241S–244S. 6 indexed citations

McKenney, James M., et al.. (1987). Effect of High-Dose Ibuprofen on 24-Hour Blood Pressure in Healthy Women. Drug Intelligence & Clinical Pharmacy. 21(6). 517–521. 11 indexed citations

McKenney, James M., Robert P. Goodman, & Jackson T. Wright. (1986). Use of antihypertensive agents in patients with glucose intolerance. American Journal of Health-System Pharmacy. 43(1). 178–189. 6 indexed citations

Goodman, Robert P., et al.. (1986). The effect of phenylpropanolamine on ambulatory blood pressure. Clinical Pharmacology & Therapeutics. 40(2). 144–147. 27 indexed citations

McKenney, James M., et al.. (1986). The Effect of Low‐Dose Hydrochlorothiazide on Blood Pressure, Serum Potassium, and Lipoproteins. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 6(4). 179–184. 41 indexed citations

McKenney, James M., et al.. (1985). The Effect of Ranitidine and Cimetidine on Single‐dose Diltiazem Pharmacokinetics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 5(1). 16–19. 24 indexed citations

10.

Goodman, Robert P., et al.. (1985). Inhibition of platelet aggregation and thromboxane production by pinacidil. Prostaglandins Leukotrienes and Medicine. 19(2). 115–122. 3 indexed citations

11.

Watson, Michael L., Robert P. Goodman, John R. Gill, et al.. (1984). Endogenous Prostacyclin Synthesis Is Decreased during Activation of the Renin-Angiotensin System in Man*. The Journal of Clinical Endocrinology & Metabolism. 58(2). 304–308. 10 indexed citations

12.

Wright, Jackson T., et al.. (1984). Cimetidine and dapsone acetylation.. Drug Metabolism and Disposition. 12(6). 782–783. 14 indexed citations

13.

Goodman, Robert P., Allen P. Killam, Alan Brash, & Robert A. Branch. (1982). Prostacyclin production during pregnancy: Comparison of production during normal pregnancy and pregnancy complicated by hypertension. American Journal of Obstetrics and Gynecology. 142(7). 817–822. 185 indexed citations

14.

Jackson, Edwin K., Robert P. Goodman, Garrett Fitzgerald, John A. Oates, & R A Branch. (1982). Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.. Journal of Pharmacology and Experimental Therapeutics. 221(1). 183–187. 12 indexed citations

15.

Goodman, Robert P. & Alan Brash. (1981). Measurement of 5,8,11, 14-icosatetraynoic acid in plasma by gas-liquid chromatography. Journal of Lipid Research. 22(3). 541–543. 1 indexed citations

16.

Goodman, Robert P. & James M. Collins. (1974). DNA in the Core of the Calf Lens. Experimental Biology and Medicine. 145(3). 928–931. 1 indexed citations

17.

Bergstrom, Ted & Robert P. Goodman. (1973). Private Demands for Public Goods. American Economic Review. 63(3). 280–296. 698 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact